Ted Breck

Ted Breck Overview

Investor Type Angel
Status Active
Investments 1
Exits 1

Ted Breck General Information


Mr. Ted Breck serves as Managing Director at TPG Biotech. Mr. Breck leads TPG's Life Sciences structured investments for mid and late-stage pharma pipeline assets, drug launches and drug royalty monetizations. Previously, Mr. Breck led the effort at TPG-Axon Capital for three years where they invested over $1.3 billion in such structured financings. Prior to joining TPG in 2005, Mr. Breck had nearly two decades of experience in healthcare investment banking at Lehman Brothers in New York and subsequently, San Francisco, where he led the firm's West Coast Life Sciences business in financing and merger and acquisition transactions. Mr. Breck received his B.A. at the University of California at Berkeley. Mr. Breck is a member of the Advisory Council of the J. David Gladstone Institutes, an independent, non-profit biomedical research organization affiliated with the University of California, San Francisco.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)

Ted Breck Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000 18-Mar-2014 0000 00000 00.00 Social/Platform Software Generating Revenue 000 00000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ted Breck Exits (1)

To view Ted Breck‘s complete exit history, request access >>
Company Name Exit Date Exit Type Exit Size
0000000 18-Sep-2018 000000000000000000 00000

Ted Breck Team (1)

Name Title Deals Funds Boards Office
Ted Breck Angel Investor 0